Evidence map›Paper›PMID 38611098›Full record

ArticleCancers2024

Growth Charts for Shwachman-Diamond Syndrome at Ages 0 to 18 Years.

Anna Pegoraro, Valentino Bezzerri, Gloria Tridello, Cecilia Brignole, Francesca Lucca, Emily Pintani, Cesare Danesino, Simone Cesaro, Francesca Fioredda, Marco Cipolli

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Anna PegoraroCystic Fibrosis Center, Azienda Ospedaliera Universitaria Integrata, 37126 Verona, Italy.
Valentino BezzerriCystic Fibrosis Center, Azienda Ospedaliera Universitaria Integrata, 37126 Verona, Italy.ORCID 0000-0002-6849-4487
Gloria TridelloCystic Fibrosis Center, Azienda Ospedaliera Universitaria Integrata, 37126 Verona, Italy.
Cecilia BrignoleCystic Fibrosis Center, Azienda Ospedaliera Universitaria Integrata, 37126 Verona, Italy.
Francesca LuccaCystic Fibrosis Center, Azienda Ospedaliera Universitaria Integrata, 37126 Verona, Italy.
Emily PintaniCystic Fibrosis Center, Azienda Ospedaliera Universitaria Integrata, 37126 Verona, Italy.
Cesare DanesinoDepartment of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.ORCID 0000-0002-8400-5671
Simone CesaroPediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, 37126 Verona, Italy.ORCID 0000-0002-8698-9547
Francesca FioreddaUnit of Hematology, IRCCS G. Gaslini Hospital, 16147 Genoa, Italy.
Marco CipolliCystic Fibrosis Center, Azienda Ospedaliera Universitaria Integrata, 37126 Verona, Italy.ORCID 0000-0001-5652-7248
Azienda Ospedaliera Universitaria Integrata Verona · ITIstituto Giannina Gaslini · ITUniversity of Pavia · IT

Funding

Associazione Italiana Sindrome di Shwachman-Diamond (AISS) 04/2024
6 · The paper itself

Abstract

Shwachman-Diamond syndrome (SDS) is one of the most common inherited bone marrow failure syndromes. SDS is characterized by hypocellular bone marrow, with a severe impairment of the myeloid lineage, resulting in neutropenia, thrombocytopenia, and, more rarely, anemia. Almost 15% of patients with SDS develop myelodysplastic syndrome or acute myeloid leukemia as early as childhood or young adulthood. Exocrine pancreatic insufficiency is another common feature of SDS. Almost all patients with SDS show failure to thrive, which is associated with skeletal abnormalities due to defective ossification. Considering these observations, it remains unfeasible to use the common growth charts already available for the general population. To address this issue, we report how we drew up growth charts of patients with SDS aged 0 to 18 years. We analyzed height, weight, and body max index (BMI) in 121 Italian patients with SDS. Results indicated that the 50th and 3rd percentiles of weight and height of the pediatric general population correspond to the 97th and 50th percentiles of patients with SDS aged 0-18 years, respectively. In addition, the percentage increment in weight of subjects aged 14-18 years was higher in patients with SDS than in the general population. SDS-specific growth charts, such as those described here, afford a new tool, which is potentially useful for both clinical and research purposes in SDS.

Indexed as

bone marrow failurepancreatic insufficiencyribosomopathyShwachman–Diamond syndrome

Identifiers

PMID38611098
PMCPMC11010856
OpenAlexW4394572374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.